FDA Inspection 585853 — Alexey B. Blokhin, M.D., Ph.D.
The FDA completed an inspection of Alexey B. Blokhin, M.D., Ph.D. on May 22, 2009 in Moscow. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 22, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Moscow (Russia)
Additional Details
Clinical Investigator (CI)